I am interested in comparing samples of type A to samples of type B. There are several RNA-seq datasets in GEO that have either type A or type B, but not both. Is it possible to take samples from two different datasets and compare them? I am guessing most of the observed differences will be between the two labs and not between the two conditions. Is that a reasonable concern? Is there a proper way to deal with that?
Unconfigured Ad
Collapse
X
-
I'd be very hesitant to do such a comparison due to the uncontrolled batch effect. I suppose you could try to estimate what sort of batch effect exists by looking at the effect between only the B or A samples, but I'm not sure how well that would work in practice.
-
Since with sequencing, there is much more confidence in the observations, which have a built in noise check during the mapping, and it is necessary to account for the overall differences in reads anyway comparing samples from different labs should be straight forward, unlike micro arrays, where batch effects were known to dominate in some cases requiring a high number of technical replicates.
After taking overall read depth into account, you would have to look for subtle effects like bias in GC annealing temperatures or PCR duplicates. Verifying the results in the lab may be difficult though, as with any meta-analysis.
Comment
-
There are still batch effects in RNAseq, though they're certainly less of an issue than in the microarray days. I happen to be looking at all of the publicly available mouse hippocampus RNAseq datasets at the moment and decided to create a little heatmap of the variance stabilised data, which you can find below. The datasets are color coded the same on the rows and columns to make life easier (there are 160 samples in the heatmap, so the labels are illegible). While there are obvious experimental differences in some of these datasets, there's still a lab batch-effect. Having said that, if you're interested in different organs or something like that then the difference due to that will be vastly greater than the batch-effect, so rskr's advise should hold-up quite well.
BTW, some of the red-colored samples are technical replicates that I never bothered merging, which is why they cluster the way they do.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment